| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for ArQule Inc. > News item |
Biotechnology Value Fund affiliates report 23.3% stake in ArQule
By Laura Lutz
Des Moines, March 13 - Affiliates of Biotechnology Value Fund, LP reported ownership of 10,162,060 shares, or 23.3%, of the common stock of ArQule, Inc. in a schedule 13D filing with the Securities and Exchange Commission.
Between Jan. 10 and March 10, the investors acquired 4,156,510 shares of ArQule at prices ranging from $3.10 to $5.10.
ArQule is a biotechnology company based in Woburn, Mass.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.